Skip to content

Clinical trials

Basal Cell Carcinoma trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Phase: Not applicable Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20061
20073
20081
20091
20101
20116
20127
20131
20142
20158
20163
20172
20186
20192
20207
20219
20226
20234
20246
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status20
Recruiting10
Active, not recruiting6
Withdrawn4
Terminated3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alpha Tau Medical LTD.6
University of Rochester4
Bispebjerg Hospital2
Maastricht University Medical Center2
Mayo Clinic2
Norwegian University of Science and Technology2
University Hospital, Bordeaux2
University of California, Davis2
University of California, San Diego2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma92
Carcinoma, Squamous Cell33
Skin Neoplasms24
Melanoma17
Squamous Cell Carcinoma of Head and Neck7
Lip Neoplasms6
Cutaneous Squamous Cell Carcinoma5
Sarcoma, Kaposi5
Soft Tissue Neoplasms5
Tongue Neoplasms5

Trials

Showing 51 to 75 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.